Comparison of Different Frames of Numerical Information in Cochrane Plain Language Summaries
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03554252 |
|
Recruitment Status :
Completed
First Posted : June 13, 2018
Last Update Posted : September 25, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Health Knowledge, Attitudes, Practice | Other: Frequencies Other: Percentages | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 225 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Investigator) |
| Primary Purpose: | Other |
| Official Title: | Comparison of Different Frames of Numerical Information in Cochrane Plain Language: Randomized Controlled Trial |
| Actual Study Start Date : | April 1, 2018 |
| Actual Primary Completion Date : | August 1, 2018 |
| Actual Study Completion Date : | August 1, 2018 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: Frequencies |
Other: Frequencies
Results are presented as natural frequencies (e.g. the drug was effective for 1 out of 10 people) while side effects are presented as percentages (e.g. 40% participants experienced severe side effects) |
| Experimental: Percentages |
Other: Percentages
Results are presented as percentages (e.g. the drug was effective for 10% of people) while side effects are presented as natural frequencies (e.g. 4 out of 10 participants experienced severe side effects) |
- Understanding [ Time Frame: 3 months ]Number of the correct answers about the content of the summary, which will consist of four multiple choice questions (with four possible answers where only one is correct, for each question) about the text the participants are reading. Questions will be developed by research team and revised by expert in health communication. The scale ranges from 0-4, where greater score indicates better understanding of the material.
- Attitudes towards the appropriateness of this type of presentation of health information [ Time Frame: 3 months ]Likert type scale from 1-10 (1 indicating low appropriateness and 10 would be completely appropriate presentation)
- Health numeracy [ Time Frame: 3 months ]5 questions about the numerical tasks placed in medical content, total score is number of correct answers on those questions. The five questions are part of Numeracy Understanding in Medicine Instrument (Schapira et al, 2012), and we will translate only the questions focusing on Probability section. Cronbach's alpha in previous research was 0.86 (Schapira et al, 2012). The questions will be revised by independent translator and back translated to English. The scale range is from 0-5, where higher score indicates higher numeracy levels.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 99 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients who are visiting their family doctor, and are at least 18 old. Students of biomedical studies at University of Split School of Medicine, who are at least 18 years old.
Exclusion Criteria:
- Participants younger than 18 years.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03554252
| Croatia | |
| University of Split School of Medicine | |
| Split, Croatia, 21000 | |
| Principal Investigator: | Ivan Buljan, MPsy | PhD student |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | University of Split, School of Medicine |
| ClinicalTrials.gov Identifier: | NCT03554252 |
| Other Study ID Numbers: |
214-09-7672 |
| First Posted: | June 13, 2018 Key Record Dates |
| Last Update Posted: | September 25, 2018 |
| Last Verified: | May 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

